Prevalence of Ultrasound-Detected Knee Synovial Features in the General Population: Xiangya Osteoarthritis (XO) Study
T. Jiang,Y. Wang,W. Zhang,M. Doherty,J. Wei,T. Yang,A. Sarmanova,X. Li,D. Xie,J. Li,G. Fernandes,A. Obotiba,S. Gohir,P. Courtney,C. Zeng,Y. Zhang,G. Lei
DOI: https://doi.org/10.1016/j.joca.2020.02.460
IF: 7.507
2020-01-01
Osteoarthritis and Cartilage
Abstract:Purpose: Synovial hypertrophy and joint effusion are two synovial changes that may associated with pain in knee osteoarthritis (KOA). Most previous population studies have used radiographs as the imaging modality for KOA; however, radiographs are unable to assess synovial hypertrophy and effusion. Compared with magnetic resonance imaging (MRI), ultrasonography (US) is a less expensive and more accessible imaging modality. Moreover, previous studies have shown that US has similar accuracy as MRI in assessment of synovial hypertrophy and joint effusion in people with symptomatic KOA. To date, few studies have used US to identify synovial hypertrophy and joint effusion of knees in a general population setting. We conducted a study to estimate the prevalence of US-detected synovial hypertrophy and joint effusion of knees in a large general population sample of middle-aged and elderly men and women. Methods: Participants (≥50 years) included in the study were from the Xiangya Osteoarthritis (XO) Study, a population-based longitudinal study conducted in the rural areas of China. US of knees was performed by a single ultrasonographer at the XO baseline examination (during 2017 and 2018). The maximal synovial thickness and depth of effusion were measured in millimeters (mm) in the suprapatellar recess according to a protocol from the Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT). Intra-reader correlation coefficients were assessed by re-reading 20 knee US images at a minimum of 12 weeks after acquisition. We defined presence of synovial hypertrophy (i.e., synovial thickness ≥ 4 mm) and joint effusion (i.e., depth of effusion ≥ 4 mm) according to the European League Against Rheumatology (EULAR) criteria. Participants having at least one knee with synovial hypertrophy or joint effusion were considered as positive for presence of synovial hypertrophy or joint effusion. The knee with the higher synovial thickness or depth of effusion was considered as the index knee for each participant. We divided participants into three age groups: 50-59, 60-69, and ≥ 70 years. We calculated the age- and sex-specific prevalence of synovial hypertrophy and effusion and compared the prevalence of these two US-detected synovial features between men and women as well as among three age categories using logistic regression model. Results: A total of 2,428 participants (1,050 men and 1,378 women, mean age ± SD: 64.4 ± 9 years) were included in this study. Intra-reader correlation coefficient was 0.842 for synovial hypertrophy and 0.745 for effusion, respectively. The mean synovial thickness was 2.8 ± 1.9 mm (men 2.8±1.9, women 2.7±1.8), and the mean depth of effusion was 4.4 ± 2.8 mm (men 4.5 ±2.4, women 4.3±2.4). The prevalence of synovial hypertrophy and joint effusion were 19.7% and 49.3%, respectively. As shown in Figure 1 and Table 1, the prevalence of synovial hypertrophy increased with age in both men and women. Compared with participants age between 50 and 59 years, the sex-adjusted prevalence ratio of prevalence of synovial hypertrophy was 1.85 (95% CI: 1.42-2.41) for those age between 60 and 69 years and 2.46 (95% CI: 1.88-3.22) for those age > 70 years old (P for trend < 0.001). Prevalence of synovial hypertrophy was slightly higher in men than in women, mainly limited to those age between 50 and 59 years old, with an age-adjusted prevalence ratio of synovial hypertrophy for men vs. women was 1.20 (95% CI: 0.98-1.49). The prevalence of synovial effusion also increased with age. Compared with participants age between 50-59 years, the sex-adjusted prevalence ratio was 1.23 (95% CI: 1.02-1.49) and 1.60 (95% CI: 1.30-1.96) for those age between 60-69 years and > 70 years, respectively (P for trend <0.001). Prevalence of effusion was higher in men than in women in all three age groups, with an age-adjusted prevalence ratio of effusion for men vs. women being 1.21 (95% CI: 1.03 - 1.42). Conclusions: US-detected knee synovial hypertrophy and joint effusion are both commonly present in the middle-aged and elderly population. The prevalence of both synovial hypertrophy and joint effusion increased with age and were higher in men than in women.Tabled 1Table 1. Prevalence of knee synovial hypertrophy or joint effusionAge, yearsSynovial hypertrophy, %Joint effusion, %MenWomenMenWomenAll (n=2,428)21.918.052.447.150-59 (n=799)17.59.545.742.560-69 (n=917)21.620.652.147.0≥70 (n=712)26.326.058.853.2 Open table in a new tab